{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:32:11Z","timestamp":1790821931366,"version":"4.1.0"},"reference-count":141,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,3,26]]},"abstract":"<jats:sec><jats:title\/><jats:p>During the last two decades, the production of pharmaceutical proteins in plants evolved from proof of concept to established technology adopted by several biotechnological companies. This progress is particularly based on intensive research starting stable genetic transformation and moving to transient expression. Due to its advantages in yield and speed of protein production transient expression platforms became the leading plant-based manufacturing technology. Current transient expression methods rely on Agrobacteriummediated delivery of expression vectors into plant cells. In recent years, great advances have been made in the improvement of expression vectors, host cell engineering as well as in the development of commercial manufacturing processes. Several GMP-certified large-scale production facilities exist around the world to utilize agroinfiltration method. A number of pharmaceutical proteins produced by transient expression are currently in clinical development. The great potential of transient expression platform in respect to rapid response to emerging pandemics was demonstrated by the production of experimental ZMapp antibodies against Ebola virus as well as influenza vaccines. This review is focused on current design, status and future perspectives of plant transient expression system for the production of biopharmaceutical proteins.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867324666170718114724","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T12:03:12Z","timestamp":1500465792000},"page":"365-380","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Transient Production of Recombinant Pharmaceutical Proteins in Plants: Evolution and Perspectives"],"prefix":"10.2174","volume":"26","author":[{"given":"Lilya","family":"Kopertekh","sequence":"first","affiliation":[{"name":"Federal Research Centre for Cultivated Plants, Institute for Biosafety in Plant Biotechnology, Erwin-Baur- Str. 27, D-06484, Quedlinburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Schiemann","sequence":"additional","affiliation":[{"name":"Federal Research Centre for Cultivated Plants, Institute for Biosafety in Plant Biotechnology, Erwin-Baur- Str. 27, D-06484, Quedlinburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"794","volume":"4","author":"Ma J.K.","year":"2003","unstructured":"Ma JK, Drake PM, Christou P. The production of recombinant pharmaceutical proteins in plants.","journal-title":"Nat Rev Genet"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tibtech.2003.10.002","volume":"21","author":"Twyman R.M.","year":"2003","unstructured":"Twyman RM, Stoger E, Schillberg S, Christou P, Fischer R. Molecular farming in plants: Host systems and expression technology.","journal-title":"Trends Biotechnol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.3390\/ijms12053220","volume":"12","author":"Thomas D.R.","year":"2011","unstructured":"Thomas DR, Penney CA, Majumder A, Walmsley AM. Evolution of plant-made pharmaceuticals.","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/07352689.2011.616075","volume":"31","author":"Nagels B.","year":"2012","unstructured":"Nagels B, Weterings K, Callewaert N, Van Damme EJM. Production of plant made pharmaceuticals: From plant host to functional protein.","journal-title":"Crit Rev Plant Sci"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"136419","DOI":"10.1155\/2014\/136419","volume":"2014","author":"Merlin M.","year":"2014","unstructured":"Merlin M, Gecchele E, Capaldi S, Pezzotti M, Avesani L. Comparative evaluation of recombinant protein production in different biofactories: The green perspective.","journal-title":"BioMed Res Int"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"28549","DOI":"10.3390\/ijms161226122","volume":"16","author":"Yao J.","year":"2015","unstructured":"Yao J, Weng Y, Dickey A, Wang KY. Plants as facto-ries for human pharmaceuticals: Applications and challenges.","journal-title":"Int J Mol Sci"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00034942","volume":"6","author":"Barta A.","year":"1986","unstructured":"Barta A, Sommergruber K, Thompson D, Hartmuth K, Matzke MA, Matzke AJ. The expression of a nopaline synthase - human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue.","journal-title":"Plant Mol Biol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1073\/pnas.89.24.11745","volume":"89","author":"Mason H.S.","year":"1992","unstructured":"Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/342076a0","volume":"342","author":"Hiatt A.","year":"1989","unstructured":"Hiatt A, Cafferkey R, Bowdish K. Production of antibodies in transgenic plants.","journal-title":"Nature"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2012.06.012","volume":"433","author":"Hefferon K.L.","year":"2012","unstructured":"Hefferon KL. Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins.","journal-title":"Virology"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11103-013-0036-1","volume":"83","author":"Peyret H.","year":"2013","unstructured":"Peyret H, Lomonossoff GP. The pEAQ vector series: The easy and quick way to produce recombinant proteins in plants.","journal-title":"Plant Mol Biol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/82_2013_352","volume":"375","author":"Gleba Y.Y.","year":"2014","unstructured":"Gleba YY, Tus\u00e9 D, Giritch A. Plant viral vectors for delivery by Agrobacterium.","journal-title":"Plant Viral Vectors"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/82_2012_212","volume":"375","author":"Klimyuk V.","year":"2014","unstructured":"Klimyuk V, Pogue G, Herz S, Butler J, Haydon H. Production of recombinant antigens and antibodies in nicotiana benthamiana using \u2018magnifection\u2019 technology: GMP-compliant facilities for small- and large-scale manufacturing.","journal-title":"Plant Viral Vectors"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/pbi.12412","volume":"13","author":"Peyret H.","year":"2015","unstructured":"Peyret H, Lomonossoff GP. When plant virology met : The rise of the deconstructed clones.","journal-title":"Plant Biotechnol J"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.aaf6638","volume":"353","author":"Lomonossoff G.P.","year":"2016","unstructured":"Lomonossoff GP, D\u2019Aoust MA. Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment.","journal-title":"Science"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1470-8744.1999.tb00900.x","volume":"30","author":"Fischer R.","year":"1999","unstructured":"Fischer R, Vaquero-Martin C, Sack M, Drossard J, Emans N, Commandeur U. Towards molecular farming in the future: Transient protein expression in plants.","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/pbi.12426","volume":"13","author":"Paul M.J.","year":"2015","unstructured":"Paul MJ, Thangaraj H, Ma JK. Commercialization of new biotechnology: A systematic review of 16 commercial case studies in a novel manufacturing sector.","journal-title":"Plant Biotechnol J"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/bab.6","volume":"58","author":"Paul M.","year":"2011","unstructured":"Paul M, Ma JK. Plant-made pharmaceuticals: Leading products and production platforms.","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.2174\/1381612811319310003","volume":"19","author":"Paul M.J.","year":"2013","unstructured":"Paul MJ, Teh AY, Twyman RM, Ma JK. Target product selection - where can Molecular Pharming make the difference?","journal-title":"Curr Pharm Des"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4161\/hv.7.3.14207","volume":"7","author":"Yusibov V.","year":"2011","unstructured":"Yusibov V, Streatfield SJ, Kushnir N. Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond.","journal-title":"Hum Vaccin"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4161\/hv.7.3.14266","volume":"7","author":"Whaley K.J.","year":"2011","unstructured":"Whaley KJ, Hiatt A, Zeitlin L. Emerging antibody products and Nicotiana manufacturing.","journal-title":"Hum Vaccin"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.biotechadv.2011.08.007","volume":"30","author":"Fischer R.","year":"2012","unstructured":"Fischer R, Schillberg S, Hellwig S, Twyman RM, Drossard J. GMP issues for plant derived recombinant pro-teins.","journal-title":"Biotechnol Adv"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.2174\/1381612811319310002","volume":"19","author":"Fischer R.","year":"2013","unstructured":"Fischer R, Schillberg S, Buyel JF, Twyman RM. Commercial aspects of pharmaceutical protein production in plants.","journal-title":"Curr Pharm Des"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bcp.13041","volume":"83","author":"Drake P.M.","year":"2017","unstructured":"Drake PM, Szeto TH, Paul MJ, Teh AY, Ma JK. Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?","journal-title":"Br J Clin Pharmacol"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biologicals.2008.09.001","volume":"36","author":"Mett V.","year":"2008","unstructured":"Mett V, Farrance CE, Green BJ, Yusibov V. Plants as biofactories.","journal-title":"Biologicals"},{"key":"ref=26","volume":"2015","author":"Chen Q.","year":"2015","unstructured":"Chen Q, Lai L. Gene Delivery into Plant Cells for Recom-binant Protein Production.","journal-title":"BioMed Res Int"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/310511a0","volume":"310","author":"Brisson N.","year":"1984","unstructured":"Brisson N, Paszkowski J, Penswick JR, Gronenborn B, Potrykus I, Hohn T. Expression of a bacterial gene in plants.","journal-title":"Nature"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1002\/j.1460-2075.1984.tb02203.x","volume":"3","author":"Dixon L.K.","year":"1984","unstructured":"Dixon LK, Hohn T. Initiation of translation of the cauliflower mosaic virus genome from a polycistronic mRNA: evidence from deletion mutagenesis.","journal-title":"EMBO J"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-3527(02)58003-9","volume":"58","author":"Awram P.","year":"2002","unstructured":"Awram P, Gardner RC, Forster RL, Bellamy AR. The potential of plant viral vectors and transgenic plants for subunit vaccine production.","journal-title":"Adv Virus Res"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.phyto.40.021102.150133","volume":"40","author":"Pogue G.P.","year":"2002","unstructured":"Pogue GP, Lindbo JA, Garger SJ, Fitzmaurice WP. Making an ally from an enemy: Plant virology and the new agriculture.","journal-title":"Annu Rev Phytopathol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/02648725.2002.10648031","volume":"19","author":"Porta C.","year":"2002","unstructured":"Porta C, Lomonossoff GP. Viruses as vectors for the expression of foreign sequences in plants.","journal-title":"Biotechnol Genet Eng Rev"},{"key":"ref=32","first-page":"67","volume":"24","author":"Scholthof K.B.","year":"2002","unstructured":"Scholthof KB, Mirkov TE, Scholthof HB. Plant virus gene vectors: Biotechnology applications in agriculture and medicine.","journal-title":"Genet Eng (N Y)"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcp.21423","volume":"216","author":"Lico C.","year":"2008","unstructured":"Lico C, Chen Q, Santi L. Viral vectors for production of recombinant proteins in plants.","journal-title":"J Cell Physiol"},{"key":"ref=34","first-page":"90","volume":"4","author":"Bey P.","year":"2010","unstructured":"Bey P, Binaghi M, Mentaberry AN, Zelada AM. Plant viral vectors as a tool for recombinant vaccine production.","journal-title":"The Americas Journal of Plant Science and Biotechnology"},{"key":"ref=35","first-page":"19","volume":"375","author":"Rybicki E.P.","year":"2014","unstructured":"Rybicki EP, Martin DP. Virus-derived ssDNA vectors for the expression of foreign proteins in plants.","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"785382","DOI":"10.1155\/2014\/785382","volume":"2014","author":"Hefferon K.","year":"2014","unstructured":"Hefferon K. Plant virus expression vector development: New perspectives.","journal-title":"BioMed Res Int"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11103-014-0279-5","volume":"87","author":"Salazar-Gonz\u00e1lez J.A.","year":"2015","unstructured":"Salazar-Gonz\u00e1lez JA, Ba\u00f1uelos-Hern\u00e1ndez B, Rosales-Mendoza S. Current status of viral expression systems in plants and perspectives for oral vaccines development.","journal-title":"Plant Mol Biol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pbi.2004.01.003","volume":"7","author":"Gleba Y.","year":"2004","unstructured":"Gleba Y, Marillonnet S, Klimyuk V. Engineering viral expression vectors for plants: The \u2018full virus\u2019 and the \u2018deconstructed virus\u2019 strategies.","journal-title":"Curr Opin Plant Biol"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.copbio.2007.03.002","volume":"18","author":"Gleba Y.","year":"2007","unstructured":"Gleba Y, Klimyuk V, Marillonnet S. Viral vectors for the expression of proteins in plants.","journal-title":"Curr Opin Biotechnol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0065-3527(08)60865-9","volume":"38","author":"Dawson W.O.","year":"1990","unstructured":"Dawson WO, Lehto KM. Regulation of tobamovirus gene expression.","journal-title":"Adv Virus Res"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/viro.1998.9579","volume":"255","author":"Shivprasad S.","year":"1999","unstructured":"Shivprasad S, Pogue GP, Lewandowski DJ, Hidalgo J, Donson J, Grill LK, Dawson WO. Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors.","journal-title":"Virology"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1365-313X.2002.01308.x","volume":"30","author":"Toth R.L.","year":"2002","unstructured":"Toth RL, Pogue GP, Chapman S. Improvement of the movement and host range properties of a plant virus vector through DNA shuffling.","journal-title":"Plant J"},{"key":"ref=43","first-page":"53","volume":"13","author":"Turpen T.H.","year":"1995","unstructured":"Turpen TH, Reinl SJ, Charoenvit Y, Hoffman SL, Fallarme V, Grill LK. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus.","journal-title":"Biotechnology (N Y)"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1073\/pnas.0901506106","volume":"106","author":"O\u2019Keefe B.R.","year":"2009","unstructured":"O\u2019Keefe BR, Vojdani F, Buffa V, Shattock RJ, Montefiori DC, Bakke J, Mirsalis J, d\u2019Andrea AL, Hume SD, Bratcher B, Saucedo CJ, McMahon JB, Pogue GP, Palmer KE. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1467-7652.2009.00495.x","volume":"8","author":"Pogue G.P.","year":"2010","unstructured":"Pogue GP, Vojdani F, Palmer KE, Hiatt E, Hume S, Phelps J, Long L, Bohorova N, Kim D, Pauly M, Velasco J, Whaley K, Zeitlin L, Garger SJ, White E, Bai Y, Haydon H, Bratcher B. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems.","journal-title":"Plant Biotechnol J"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.embor.7400470","volume":"6","author":"Ma J.K.","year":"2005","unstructured":"Ma JK, Barros E, Bock R, Christou P, Dale PJ, Dix PJ, Fischer R, Irwin J, Mahoney R, Pezzotti M, Schillberg S, Sparrow P, Stoger E, Twyman RM. Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants.","journal-title":"EMBO Rep"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1073\/pnas.96.2.703","volume":"96","author":"McCormick A.A.","year":"1999","unstructured":"McCormick AA, Kumagai MH, Hanley K, Turpen TH, Hakim I, Grill LK, Tus\u00e9 D, Levy S, Levy R. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1073\/pnas.0803636105","volume":"105","author":"McCormick A.A.","year":"2008","unstructured":"McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F, Hanley KM, Garger SJ, White EL, Novak J, Barrett J, Holtz RB, Tus\u00e9 D, Levy R. Plant-produced idiotype vaccines for the treatment of non-Hodgkin\u2019s lymphoma: safety and immunogenicity in a phase I clinical study.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-313X.1992.t01-24-00999.x","volume":"2","author":"Chapman S.","year":"1992","unstructured":"Chapman S, Kavanagh T, Baulcombe D. Potato virus X as a vector for gene expression in plants.","journal-title":"Plant J"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"8434","DOI":"10.1128\/JVI.75.18.8434-8439.2001","volume":"75","author":"Marusic C.","year":"2001","unstructured":"Marusic C, Rizza P, Lattanzi L, Mancini C, Spada M, Belardelli F, Benvenuto E, Capone I. Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1.","journal-title":"J Virol"},{"key":"ref=51","first-page":"3654","volume":"62","author":"Franconi R.","year":"2002","unstructured":"Franconi R, Di Bonito P, Dibello F, Accardi L, Muller A, Cirilli A, Simeone P, Don\u00e0 MG, Venuti A, Giorgi C. Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection.","journal-title":"Cancer Res"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00705-004-0402-z","volume":"150","author":"Uhde K.","year":"2005","unstructured":"Uhde K, Fischer R, Commandeur U. Expression of multiple foreign epitopes presented as synthetic antigens on the surface of Potato virus X particles.","journal-title":"Arch Virol"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jviromet.2005.06.020","volume":"131","author":"Mechtcheriakova I.A.","year":"2006","unstructured":"Mechtcheriakova IA, Eldarov MA, Nicholson L, Shanks M, Skryabin KG, Lomonossoff GP. The use of viral vectors to produce hepatitis B virus core particles in plants.","journal-title":"J Virol Methods"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1467-7652.2006.00206.x","volume":"4","author":"Monger W.","year":"2006","unstructured":"Monger W, Alamillo JM, Sola I, Perrin Y, Bestagno M, Burrone OR, Sabella P, Plana-Duran J, Enjuanes L, Garcia JA, Lomonossoff GP. An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extracts.","journal-title":"Plant Biotechnol J"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pep.2007.09.006","volume":"58","author":"Cerovsk\u00e1 N.","year":"2008","unstructured":"Cerovsk\u00e1 N, Hoffmeisterov\u00e1 H, Pecenkov\u00e1 T, Moravec T, Synkov\u00e1 H, Plchov\u00e1 H, Velem\u00ednsk\u00fd J. Transient expression of HPV16 E7 peptide (aa 44-60) and HPV16 L2 peptide (aa 108-120) on chimeric potyvirus-like particles using Potato virus X-based vector.","journal-title":"Protein Expr Purif"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1006\/viro.1994.1417","volume":"202","author":"Porta C.","year":"1994","unstructured":"Porta C, Spall VE, Loveland J, Johnson JE, Barker PJ, Lomonossoff GP. Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides.","journal-title":"Virology"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/viro.1999.0126","volume":"267","author":"Gopinath K.","year":"2000","unstructured":"Gopinath K, Wellink J, Porta C, Taylor KM, Lomonossoff GP, van Kammen A. Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants.","journal-title":"Virology"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.vaccine.2004.11.006","volume":"23","author":"Liu L.","year":"2005","unstructured":"Liu L, Ca\u00f1izares MC, Monger W, Perrin Y, Tsakiris E, Porta C, Shariat N, Nicholson L, Lomonossoff GP. Cowpea mosaic virus-based systems for the production of antigens and antibodies in plants.","journal-title":"Vaccine"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/biot.200600143","volume":"1","author":"Alamillo J.M.","year":"2006","unstructured":"Alamillo JM, Monger W, Sola I, Garc\u00eda B, Perrin Y, Bestagno M, Burrone OR, Sabella P, Plana-Dur\u00e1n J, Enjuanes L, Lomonossoff GP, Garc\u00eda JA. Use of virus vectors for the expression in plants of active full-length and single chain anti-coronavirus antibodies.","journal-title":"Biotechnol J"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1467-7652.2007.00303.x","volume":"6","author":"Sainsbury F.","year":"2008","unstructured":"Sainsbury F, Lavoie PO, D\u2019Aoust MA, V\u00e9zina LP, Lomonossoff GP. Expression of multiple proteins using full-length and deleted versions of cowpea mosaic virus RNA-2.","journal-title":"Plant Biotechnol J"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"e13976","DOI":"10.1371\/journal.pone.0013976","volume":"5","author":"Sainsbury F.","year":"2010","unstructured":"Sainsbury F, Sack M, Stadlmann J, Quendler H, Fischer R, Lomonossoff GP. Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody.","journal-title":"PLoS One"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-9452(96)04541-4","volume":"122","author":"Kapila J.","year":"1997","unstructured":"Kapila J, de Rycke R, van Montagu M, Angenon G. An Agrobacterium-mediated transient gene expression system for intact leaves.","journal-title":"Plant Sci"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1467-7652.2009.00414.x","volume":"7","author":"V\u00e9zina L.P.","year":"2009","unstructured":"V\u00e9zina LP, Faye L, Lerouge P, D\u2019Aoust MA, Marquet-Blouin E, Burel C, Lavoie PO, Bardor M, Gomord V. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants.","journal-title":"Plant Biotechnol J"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1104\/pp.108.126284","volume":"148","author":"Sainsbury F.","year":"2008","unstructured":"Sainsbury F, Lomonossoff GP. Extremely high-level and rapid transient protein production in plants without the use of viral replication.","journal-title":"Plant Physiol"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1467-7652.2009.00434.x","volume":"7","author":"Sainsbury F.","year":"2009","unstructured":"Sainsbury F, Thuenemann EC, Lomonossoff GP. pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants.","journal-title":"Plant Biotechnol J"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.2174\/1381612811319310011","volume":"19","author":"Thuenemann E.C.","year":"2013","unstructured":"Thuenemann EC, Lenzi P, Love AJ, Taliansky M, B\u00e9cares M, Zu\u00f1iga S, Enjuanes L, Zahmanova GG, Minkov IN, Mati\u0107 S, Noris E, Meyers A, Hattingh A, Rybicki EP, Kiselev OI, Ravin NV, Eldarov MA, Skryabin KG, Lomonossoff GP. The use of transient expression systems for the rapid production of virus-like particles in plants.","journal-title":"Curr Pharm Des"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pep.2011.09.005","volume":"81","author":"Vardakou M.","year":"2012","unstructured":"Vardakou M, Sainsbury F, Rigby N, Mulholland F, Lomonossoff GP. Expression of active recombinant human gastric lipase in Nicotiana benthamiana using the CPMV-HT transient expression system.","journal-title":"Protein Expr Purif"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/pbi.12076","volume":"11","author":"Thuenemann E.C.","year":"2013","unstructured":"Thuenemann EC, Meyers AE, Verwey J, Rybicki EP, Lomonossoff GP. A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles.","journal-title":"Plant Biotechnol J"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1073\/pnas.0400149101","volume":"101","author":"Marillonnet S.","year":"2004","unstructured":"Marillonnet S, Giritch A, Gils M, Kandzia R, Klimyuk V, Gleba Y. In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nbt1094","volume":"23","author":"Marillonnet S.","year":"2005","unstructured":"Marillonnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y. Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants.","journal-title":"Nat Biotechnol"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2005.12.024","volume":"24","author":"Huang Z.","year":"2006","unstructured":"Huang Z, Santi L, LePore K, Kilbourne J, Arntzen CJ, Mason HS. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.","journal-title":"Vaccine"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.vaccine.2008.01.053","volume":"26","author":"Santi L.","year":"2008","unstructured":"Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, Chen Q, Mason HS. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles.","journal-title":"Vaccine"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1073\/pnas.0510014103","volume":"103","author":"Santi L.","year":"2006","unstructured":"Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V, Gleba Y, Webb R, Arntzen CJ, Mason HS. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1467-7652.2005.00154.x","volume":"3","author":"Gils M.","year":"2005","unstructured":"Gils M, Kandzia R, Marillonnet S, Klimyuk V, Gleba Y. High-yield production of authentic human growth hormone using a plant virus-based expression system.","journal-title":"Plant Biotechnol J"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1104\/pp.107.106377","volume":"145","author":"Lindbo J.A.","year":"2007","unstructured":"Lindbo JA. TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector.","journal-title":"Plant Physiol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1472-6750-7-52","volume":"7","author":"Lindbo J.A.","year":"2007","unstructured":"Lindbo JA. High-efficiency protein expression in plants from agroinfection-compatible expression vectors.","journal-title":"BMC Biotechnol"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1750-2659.2006.00005.x","volume":"1","author":"Musiychuk K.","year":"2007","unstructured":"Musiychuk K, Stephenson N, Bi H, Farrance CE, Orozovic G, Brodelius M, Brodelius P, Horsey A, Ugulava N, Shamloul AM, Mett V, Rabindran S, Streatfield SJ, Yusibov V. A launch vector for the production of vaccine antigens in plants.","journal-title":"Influenza Other Respir Viruses"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.vaccine.2007.01.068","volume":"25","author":"Chichester J.A.","year":"2007","unstructured":"Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V. Immunogenicity of a subunit vaccine against","journal-title":"Vaccine"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.vaccine.2007.01.017","volume":"25","author":"Mett V.","year":"2007","unstructured":"Mett V, Lyons J, Musiychuk K, Chichester JA, Brasil T. Couch., R, Sherwood, R., Palmer, G.A., Streatfield, S.J., Yusibov, V. A plant-produced plague vaccine candidate con-fers protection to monkeys.","journal-title":"Vaccine"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/hv.7.0.14561","volume":"7","author":"Shoji Y.","year":"2011","unstructured":"Shoji Y, Chichester JA, Jones M, Manceva SD, Damon E, Mett V, Musiychuk K, Bi H, Farrance C, Shamloul M, Kushnir N, Sharma S, Yusibov V. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.","journal-title":"Hum Vaccin"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"14701","DOI":"10.1073\/pnas.0606631103","volume":"103","author":"Giritch A.","year":"2006","unstructured":"Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, Gleba Y. Rapid high-yield expression of full-size IgG antibodies in plants co infected with noncompeting viral vectors.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"14645","DOI":"10.1073\/pnas.0607089103","volume":"103","author":"Hiatt A.","year":"2006","unstructured":"Hiatt A, Pauly M. Monoclonal antibodies from plants: A new speed record.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/annonc\/mdq256","volume":"21","author":"Bendandi M.","year":"2010","unstructured":"Bendandi M, Marillonnet S, Kandzia R, Thieme F, Nickstadt A, Herz S, Fr\u00f6de R, Inog\u00e9s S, L\u00f2pez-D\u00ecaz de Cerio A, Soria E, Villanueva H, Vancanneyt G, McCormick A, Tus\u00e9 D, Lenz J, Butler-Ransohoff JE, Klimyuk V, Gleba Y. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin\u2019s lymphoma.","journal-title":"Ann Oncol"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/vaccines2030642","volume":"2","author":"Hefferon K.L.","year":"2014","unstructured":"Hefferon KL. DNA Virus vectors for vaccine production in plants: spotlight on Geminiviruses.","journal-title":"Vaccines (Basel)"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4161\/hv.7.3.14262","volume":"7","author":"Chen Q.","year":"2011","unstructured":"Chen Q, He J, Phoolcharoen W, Mason HS. Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants.","journal-title":"Hum Vaccin"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1099\/0022-1317-78-8-2113","volume":"78","author":"Liu L.","year":"1997","unstructured":"Liu L, van Tonder T, Pietersen G, Davies JW, Stanley J. Molecular characterization of a subgroup I geminivirus from a legume in South Africa.","journal-title":"J Gen Virol"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/bit.10483","volume":"81","author":"Mor T.S.","year":"2003","unstructured":"Mor TS, Moon YS, Palmer KE, Mason HS. Geminivirus vectors for high-level expression of foreign proteins in plant cells.","journal-title":"Biotechnol Bioeng"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/bit.22299","volume":"103","author":"Huang Z.","year":"2009","unstructured":"Huang Z, Chen Q, Hjelm B, Arntzen C, Mason H. A DNA replicon system for rapid high-level production of virus-like particles in plants.","journal-title":"Biotechnol Bioeng"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1467-7652.2011.00593.x","volume":"9","author":"Phoolcharoen W.","year":"2011","unstructured":"Phoolcharoen W, Bhoo SH, Lai H, Ma J, Arntzen CJ, Chen Q, Mason HS. Expression of an immunogenic Ebola immune complex in","journal-title":"Plant Biotechnol J"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-7652.2011.00649.x","volume":"10","author":"Lai H.","year":"2012","unstructured":"Lai H, He J, Engle M, Diamond MS, Chen Q. Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce.","journal-title":"Plant Biotechnol J"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1467-7652.2009.00462.x","volume":"8","author":"Regnard G.L.","year":"2010","unstructured":"Regnard GL, Halley-Stott RP, Tanzer FL, Hitzeroth II, Rybicki EP. High level protein expression in plants through the use of a novel autonomously replicating gemini virus shuttle vector.","journal-title":"Plant Biotechnol J"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12985-014-0205-0","volume":"11","author":"Rybicki E.P.","year":"2014","unstructured":"Rybicki EP. Plant-based vaccines against viruses.","journal-title":"Virol J"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00299-007-0335-6","volume":"26","author":"Reavy B.","year":"2007","unstructured":"Reavy B, Bagirova S, Chichkova NV, Fedoseeva SV, Kim SH, Vartapetian AB, Taliansky ME. Caspase-resistant VirD2 protein provides enhanced gene delivery and expression in plants.","journal-title":"Plant Cell Rep"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1094\/MPMI-05-15-0102-R","volume":"28","author":"Denkovskien\u0117 E.","year":"2015","unstructured":"Denkovskien\u0117 E, Pa\u0161kevi\u010dius \u0160, Werner S, Gleba Y, Ra\u017eanskien\u0117 A. Inducible expression of agrobacterium virulence gene VirE2 for stringent regulation of T-DNA transfer in plant transient expression systems.","journal-title":"Mol Plant Microbe Interact"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1094\/MPMI-21-8-1015","volume":"21","author":"Goodin M.M.","year":"2008","unstructured":"Goodin MM, Zaitlin D, Naidu RA, Lommel SA. : Its history and future as a model for plant-pathogen interactions.","journal-title":"Mol Plant Microbe Interact"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3390\/agriculture5040901","volume":"5","author":"Powell J.D.","year":"2015","unstructured":"Powell JD. From pandemic preparedness to biofuel production: Tobacco finds its biotechnology niche in North America.","journal-title":"Agriculture"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1467-7652.2011.00643.x","volume":"10","author":"Goulet C.","year":"2012","unstructured":"Goulet C, Khalf M, Sainsbury F, D\u2019Aoust MA, Michaud D. A protease activity-depleted environment for heterologous proteins migrating towards the leaf cell apoplast.","journal-title":"Plant Biotechnol J"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"e70203","DOI":"10.1371\/journal.pone.0070203","volume":"8","author":"Robert S.","year":"2013","unstructured":"Robert S, Khalf M, Goulet MC, D\u2019Aoust MA, Sainsbury F, Michaud D. Protection of recombinant mammalian antibodies from development-dependent proteolysis in leaves of","journal-title":"PLoS One"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/biot.201500056","volume":"10","author":"Jutras P.V.","year":"2015","unstructured":"Jutras PV, D\u2019Aoust MA, Couture MM, V\u00e9zina LP, Goulet MC, Michaud D, Sainsbury F. Modulating secretory pathway pH by proton channel co-expression can increase recombinant protein stability in plants.","journal-title":"Biotechnol J"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1467-7652.2009.00497.x","volume":"8","author":"Gomord V.","year":"2010","unstructured":"Gomord V, Fitchette AC, Menu-Bouaouiche L, Saint-Jore-Dupas C, Plasson C, Michaud D, Faye L. Plant-specific glycosylation patterns in the context of therapeutic protein production.","journal-title":"Plant Biotechnol J"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/biot.200600255","volume":"2","author":"Schuster M.","year":"2007","unstructured":"Schuster M, Jost W, Mudde GC, Wiederkum S, Schwager C, Janzek E, Altmann F, Stadlmann J, Stemmer C, Gorr G. In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system.","journal-title":"Biotechnol J"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Kaneko Y.","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.","journal-title":"Science"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.2174\/1381612811319310006","volume":"19","author":"Bosch D.","year":"2013","unstructured":"Bosch D, Castilho A, Loos A, Schots A, Steinkellner H. N-glycosylation of plant-produced recombinant proteins.","journal-title":"Curr Pharm Des"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fpls.2014.00523","volume":"5","author":"Loos A.","year":"2014","unstructured":"Loos A, Steinkellner H. Plant glyco-biotechnology on the way to synthetic biology.","journal-title":"Front Plant Sci"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.copbio.2014.06.008","volume":"30","author":"Strasser R.","year":"2014","unstructured":"Strasser R, Altmann F, Steinkellner H. Controlled glycosylation of plant-produced recombinant proteins.","journal-title":"Curr Opin Biotechnol"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1467-7652.2008.00330.x","volume":"6","author":"Strasser R.","year":"2008","unstructured":"Strasser R, Stadlmann J, Sch\u00e4hs M, Stiegler G, Quendler H, Mach L, Gl\u00f6ssl J, Weterings K, Pabst M, Steinkellner H. Generation of glyco-engineered for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.","journal-title":"Plant Biotechnol J"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/pbi.12403","volume":"14","author":"Li J.","year":"2016","unstructured":"Li J, Stoddard TJ, Demorest ZL, Lavoie PO, Luo S, Clasen BM, Cedrone F, Ray EE, Coffman AP, Daulhac A, Yabandith A, Retterath AJ, Mathis L, Voytas DF, D\u2019Aoust MA, Zhang F. Multiplexed, targeted gene editing in for glyco-engineering and monoclonal antibody production.","journal-title":"Plant Biotechnol J"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"e54836","DOI":"10.1371\/journal.pone.0054836","volume":"8","author":"Castilho A.","year":"2013","unstructured":"Castilho A, Neumann L, Gattinger P, Strasser R, Vorauer-Uhl K, Sterovsky T, Altmann F, Steinkellner H. Generation of biologically active multi-sialylated recombinant human EPOFc in plants.","journal-title":"PLoS One"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1073\/pnas.1604371113","volume":"113","author":"Kallolimath S.","year":"2016","unstructured":"Kallolimath S, Castilho A, Strasser R, Gr\u00fcnwald-Gruber C, Altmann F, Strubl S, Galuska CE, Zlatina K, Galuska SP, Werner S, Thiesler H, Werneburg S, Hildebrandt H, Gerardy-Schahn R, Steinkellner H. Engineering of complex protein sialylation in plants.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"20690","DOI":"10.1073\/pnas.1108360108","volume":"108","author":"Zeitlin L.","year":"2011","unstructured":"Zeitlin L, Pettitt J, Scully C, Bohorova N, Kim D, Pauly M, Hiatt A, Ngo L, Steinkellner H, Whaley KJ, Olinger GG. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immune protectant.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"15923","DOI":"10.1074\/jbc.M109.088401","volume":"285","author":"Castilho A.","year":"2010","unstructured":"Castilho A, Strasser R, Stadlmann J, Grass J, Jez J, Gattinger P, Kunert R, Quendler H, Pabst M, Leonard R, Altmann F, Steinkellner H. In planta protein sialylation through overexpression of the respective mammalian pathway.","journal-title":"J Biol Chem"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3322\/CA.2008.0011","volume":"58","author":"Bendandi M.","year":"2008","unstructured":"Bendandi M. Aiming at a curative strategy for follicular lymphoma.","journal-title":"CA Cancer J Clin"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/hv.7.3.14213","volume":"7","author":"Tus\u00e9 D.","year":"2011","unstructured":"Tus\u00e9 D. Safety of plant-made pharmaceuticals: product development and regulatory considerations based on case studies of two autologous human cancer vaccines.","journal-title":"Hum Vaccin"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-1759(03)00208-4","volume":"278","author":"McCormick A.A.","year":"2003","unstructured":"McCormick AA, Reinl SJ, Cameron TI, Vojdani F, Fronefield M, Levy R, Tus\u00e9 D. Individualized human scFv vaccines produced in plants: humoral antiidiotype responses in vaccinated mice confirm relevance to the tumor Ig.","journal-title":"J Immunol Methods"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4161\/hv.7.3.14163","volume":"7","author":"McCormick A.A.","year":"2011","unstructured":"McCormick AA. Tobacco derived cancer vaccines for non-Hodgkin\u2019s lymphoma: Perspectives and progress.","journal-title":"Hum Vaccin"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"648143","DOI":"10.1155\/2015\/648143","volume":"2015","author":"Tus\u00e9 D.","year":"2015","unstructured":"Tus\u00e9 D, Ku N, Bendandi M, Becerra C, Collins R, Langford N, Sancho SI, L\u00f3pez-D\u00edaz de Cerio A, Pastor F, Kandzia R, Thieme F, Jarczowski F, Krause D, Ma JK, Pandya S, Klimyuk V, Gleba Y, Butler-Ransohoff JE. Clinical safety and Immunogenicity of tumor-targeted, plant-made Id-KLH conjugate vaccines for follicular lymphoma.","journal-title":"BioMed Res Int"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","volume":"109","author":"Olinger G.G.","year":"2012","unstructured":"Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L. Delayed treatment of Ebola virus infection with plant derived monoclonal antibodies provides protection in rhesus macaques.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"199ra113","DOI":"10.1126\/scitranslmed.3006608","volume":"5","author":"Pettitt J.","year":"2013","unstructured":"Pettitt J, Zeitlin L. Kim do H., Working, C., Johnson, J.C., Bohorov, O., Bratcher, B., Hiatt, E., Hume, S.D., Johnson, A.K., Morton, J., Pauly, M.H., Whaley, K.J., Ingram, M.F., Zovanyi, A., Heinrich, M., Piper, A., Zelko, J., Olinger, G.G. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cock-tail.","journal-title":"Sci Transl Med"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","volume":"514","author":"Qiu X.","year":"2014","unstructured":"Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.","journal-title":"Nature"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","volume":"375","author":"Davey R.T.","year":"2016","unstructured":"Davey RT, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, Beigel J, Tierney J, Lane HC, Fauci AS, Massaquoi MBF, Sahr F, Malvy DA. Randomized, Controlled trial of ZMapp for Ebola Virus Infection.","journal-title":"N Engl J Med"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1467-7652.2008.00384.x","volume":"6","author":"D\u2019Aoust M.A.","year":"2008","unstructured":"D\u2019Aoust MA, Lavoie PO, Couture MM, Tr\u00e9panier S, Guay JM, Dargis M, Mongrand S, Landry N, Ward BJ, V\u00e9zina LP. Influenza virus-like particles produced by transient expression in induce a protective immune response against a lethal viral challenge in mice.","journal-title":"Plant Biotechnol J"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","volume":"8","author":"D\u2019Aoust M.A.","year":"2010","unstructured":"D\u2019Aoust MA, Couture MM, Charland N, Tr\u00e9panier S, Landry N, Ors F, V\u00e9zina LP. The production of hemagglutinin-based virus-like particles in plants: A rapid, efficient and safe response to pandemic influenza.","journal-title":"Plant Biotechnol J"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"e15559","DOI":"10.1371\/journal.pone.0015559","volume":"5","author":"Landry N.","year":"2010","unstructured":"Landry N, Ward BJ, Tr\u00e9panier S, Montomoli E, Dargis M, Lapini G, V\u00e9zina LP. Preclinical and clinical development of plant made virus-like particle vaccine against avian H5N1 influenza.","journal-title":"PLoS One"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2016.03.008","volume":"168","author":"Pillet S.","year":"2016","unstructured":"Pillet S, Aubin \u00c9, Tr\u00e9panier S, Bussi\u00e8re D, Dargis M, Poulin JF, Yassine-Diab B, Ward BJ, Landry N. A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults.","journal-title":"Clin Immunol"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.vaccine.2013.10.017","volume":"32","author":"Cummings J.F.","year":"2014","unstructured":"Cummings JF, Guerrero ML, Moon JE, Waterman P, Nielsen RK, Jefferson S, Gross FL, Hancock K, Katz JM, Yusibov V. Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults.","journal-title":"Vaccine"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3390\/v4113227","volume":"4","author":"Chichester J.A.","year":"2012","unstructured":"Chichester JA, Jones RM, Green BJ, Stow M, Miao F, Moonsammy G, Streatfield SJ, Yusibov V. Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A\/Indonesia\/05\/2005 (H5N1) influenza virus: A phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults.","journal-title":"Viruses"},{"key":"ref=127","first-page":"1235","volume":"11","author":"Major D.","year":"2015","unstructured":"Major D, Chichester JA, Pathirana RD, Guilfoyle K, Shoji Y, Guzman CA, Yusibov V, Cox RJ. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.","journal-title":"Hum Vaccin Immunother"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.vaccine.2005.01.006","volume":"23","author":"Gleba Y.","year":"2005","unstructured":"Gleba Y, Klimyuk V, Marillonnet S. Magnifection--a new platform for expressing recombinant vaccines in plants.","journal-title":"Vaccine"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/pbi.12469","volume":"13","author":"Holtz B.R.","year":"2015","unstructured":"Holtz BR, Berquist BR, Bennett LD, Kommineni VJ, Munigunti RK, White EL, Wilkerson DC, Wong KY, Ly LH, Marcel S. Commercial-scale biotherapeutics manufacturing facility for plant made pharmaceuticals.","journal-title":"Plant Biotechnol J"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/14760584.2015.989988","volume":"14","author":"Yusibov V.","year":"2015","unstructured":"Yusibov V, Kushnir N, Streatfield SJ. Advances and challenges in the development and production of effective plant-based influenza vaccines.","journal-title":"Expert Rev Vaccines"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"g5488","DOI":"10.1136\/bmj.g5488","volume":"349","author":"McCarthy M.","year":"2014","unstructured":"McCarthy M. US signs contract with ZMapp maker to accelerate development of the Ebola drug.","journal-title":"BMJ"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tibtech.2008.05.007","volume":"26","author":"Sp\u00f6k A.","year":"2008","unstructured":"Sp\u00f6k A, Twyman RM, Fischer R, Ma JK, Sparrow PA. Evolution of a regulatory framework for plant made pharmaceuticals.","journal-title":"Trends Biotechnol"},{"key":"ref=133","author":"Fischer R.","year":"2014","unstructured":"Fischer R, Buyel JF, Schillberg S, Twyman RM. Molecular farming in plants: The long road to the market","journal-title":"Commercial plant produced recombinant protein products, biotechnology in agriculture and forestry"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11248-007-9074-2","volume":"16","author":"Sparrow P.A.","year":"2007","unstructured":"Sparrow PA, Irwin JA, Dale PJ, Twyman RM, Ma JK. Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals.","journal-title":"Transgenic Res"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/pbi.12416","volume":"13","author":"Ma J.K.","year":"2015","unstructured":"Ma JK, Drossard J, Lewis D, Altmann F, Boyle J, Christou P, Cole T, Dale P, van Dolleweerd CJ, Isitt V, Katinger D, Lobedan M, Mertens H, Paul MJ, Rademacher T, Sack M, Hundleby PA, Stiegler G, Stoger E, Twyman RM, Vcelar B, Fischer R. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants.","journal-title":"Plant Biotechnol J"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/pbi.12475","volume":"13","author":"Streatfield S.J.","year":"2015","unstructured":"Streatfield SJ, Kushnir N, Yusibov V. Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents.","journal-title":"Plant Biotechnol J"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biotechadv.2014.12.006","volume":"33","author":"Bortesi L.","year":"2015","unstructured":"Bortesi L, Fischer R. The CRISPR\/Cas9 system for plant genome editing and beyond.","journal-title":"Biotechnol Adv"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.biotechadv.2011.07.020","volume":"30","author":"Wilken L.R.","year":"2012","unstructured":"Wilken LR, Nikolov ZL. Recovery and purification of plant-made recombinant proteins.","journal-title":"Biotechnol Adv"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.biotechadv.2015.04.010","volume":"33","author":"Buyel J.F.","year":"2015","unstructured":"Buyel JF, Twyman RM, Fischer R. Extraction and downstream processing of plant-derived recombinant proteins.","journal-title":"Biotechnol Adv"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4161\/bioe.28061","volume":"5","author":"Buyel J.F.","year":"2014","unstructured":"Buyel JF, Fischer R. Downstream processing of biopharmaceutical proteins produced in plants.","journal-title":"Bioengineered"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s10529-014-1621-3","volume":"36","author":"Sabalza M.","year":"2014","unstructured":"Sabalza M, Christou P, Capell T. Recombinant plant-derived pharmaceutical proteins: Current technical and economic bottlenecks.","journal-title":"Biotechnol Lett"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/154269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T16:03:45Z","timestamp":1750781025000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/154269\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":141,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867324666170718114724","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}